- |||||||||| ivermectin oral / Generic mfg.
Journal: Ivermectin in COVID-19 Management: What is the current evidence? (Pubmed Central) - Jun 11, 2022 In most studies, ivermectin was used in combination with doxycycline, azithromycin, or other drugs...In this review, articles on the prophylactic role of ivermectin in COVID-19 are also discussed - wherein the results are more promising. Despite accumulating evidence suggest the possible use of ivermectin, the final call to incorporate ivermectin in the management of COVID-19 is still inconclusive.
- |||||||||| favipiravir / Generic mfg.
Enrollment open, Combination therapy: IFCOV: Ivermectin With Favipiravir in Mild-to-moderate COVID-19 Patients (clinicaltrials.gov) - Jun 8, 2022 P2, N=200, Recruiting, In this Phase II randomised trial, single dose of 12 or 24 mg of ivermectin did not reduce viral loads, prevent symptom progression, or reduce mortality in patients with predominantly haematological illnesses who develop mild to moderate COVID 19 illness. Not yet recruiting --> Recruiting
|